Literature DB >> 28076483

SEDATION IN COLONOSCOPY BY USING THREE DIFFERENT PROPOFOL INFUSION METHODS AND ANALYSIS OF PLASMA CONCENTRATION LEVELS: A PROSPECTIVE COMPARATIVE STUDY.

Paulo Henrique Boaventura de Carvalho1, José Pinhata Otoch2, Mohamad Ali Khan3, Paulo Sakai4, Hugo Gonçalo Guedes4, Everson Luiz de Almeida Artifon2,4.   

Abstract

Background: The propofolemia becomes directly linked to the clinical effects of this anesthetic and is the focus for studies comparing propofol clinical use, in different administration methods routinely used in endoscopy units where sedation is widely administered to patients. Aim: To evaluate the effects of three different regimens of intravenous propofol infusion in colonoscopies.
Methods: A total of 50 patients that underwent colonoscopies were consecutively assigned to three groups: 1) intermittent bolus infusion; 2) continuous manually controlled infusion; 3) continuous automatic infusion. Patients were monitored with Bispectral IndexTM (BIS) and propofol serum levels were collected at three different timepoints. The development of an original dilution of propofol and an inventive capnography catheter were necessary.
Results: Regarding clinical outcomes, statistical differences in agitation (higher in group 1, p=0.001) and initial blood pressure (p=0.008) were found. As for propofol serum levels, findings were similar in consumption per minute (p=0.748) and over time (p=0.830). In terms of cost analysis, group 1 cost was R$7.00 (approximately US$2,25); group2, R$17.50 (approximately US$5,64); and group 3, R$112.70 (approximately US$36,35, p<0.001). Capnography was able to predict 100% of the oxygen saturation drop (below 90%).
Conclusion: The use of propofol bolus administration for colonoscopies, through continuous manually controlled infusion or automatic infusion are similar regarding propofolemia and the clinical outcomes evaluated. The use of an innovative capnography catheter is liable and low-cost solution for the early detection of airway obstruction.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28076483      PMCID: PMC5225868          DOI: 10.1590/0102-6720201600040012

Source DB:  PubMed          Journal:  Arq Bras Cir Dig        ISSN: 0102-6720


  10 in total

1.  Bispectral index monitoring of sedation during endoscopy.

Authors:  A L Bower; A Ripepi; J Dilger; N Boparai; F J Brody; J L Ponsky
Journal:  Gastrointest Endosc       Date:  2000-08       Impact factor: 9.427

2.  Rapid fluid infusion therapy decreases the plasma concentration of continuously infused propofol.

Authors:  Y U Adachi; M Satomoto; H Higuchi; K Watanabe
Journal:  Acta Anaesthesiol Scand       Date:  2005-03       Impact factor: 2.105

Review 3.  Target-controlled infusion versus manually-controlled infusion of propofol for general anaesthesia or sedation in adults.

Authors:  Kate Leslie; Ornella Clavisi; Joshua Hargrove
Journal:  Cochrane Database Syst Rev       Date:  2008-07-16

4.  Propofol for endoscopic sedation: A protocol for safe and effective administration by the gastroenterologist.

Authors:  Lawrence B Cohen; Amelia N Dubovsky; James Aisenberg; Kenneth M Miller
Journal:  Gastrointest Endosc       Date:  2003-11       Impact factor: 9.427

5.  Plasma propofol concentration and EEG burst suppression ratio during normothermic cardiopulmonary bypass.

Authors:  K Yoshitani; M Kawaguchi; M Takahashi; K Kitaguchi; H Furuya
Journal:  Br J Anaesth       Date:  2003-02       Impact factor: 9.166

6.  Bispectral index monitoring of conscious sedation with the combination of meperidine and midazolam during endoscopy.

Authors:  Mohammed A Qadeer; John J Vargo; Sandeep Patel; John A Dumot; A Rocio Lopez; Patricia A Trolli; Darwin L Conwell; Tyler Stevens; Gregory Zuccaro
Journal:  Clin Gastroenterol Hepatol       Date:  2007-12-11       Impact factor: 11.382

Review 7.  A systematic review and meta-analysis of randomized, controlled trials of moderate sedation for routine endoscopic procedures.

Authors:  Kenneth R McQuaid; Loren Laine
Journal:  Gastrointest Endosc       Date:  2008-05       Impact factor: 9.427

8.  Propofol sedation during endoscopic procedures: how much staff and monitoring are necessary?

Authors:  Daniel Külling; Marcello Orlandi; Werner Inauen
Journal:  Gastrointest Endosc       Date:  2007-09       Impact factor: 9.427

9.  An initial investigation of bispectral monitoring as an adjunct to nurse-administered propofol sedation for colonoscopy.

Authors:  Shawn C Chen; Douglas K Rex
Journal:  Am J Gastroenterol       Date:  2004-06       Impact factor: 10.864

10.  Propofol blood concentration and the Bispectral Index predict suppression of learning during propofol/epidural anesthesia in volunteers.

Authors:  K Leslie; D I Sessler; M Schroeder; K Walters
Journal:  Anesth Analg       Date:  1995-12       Impact factor: 5.108

  10 in total
  4 in total

Review 1.  THE IMPORTANCE OF COLONOSCOPY IN INFLAMMATORY BOWEL DISEASES.

Authors:  Márcio Alexandre Terra Passos; Fernanda Correa Chaves; Nilson Chaves-Junior
Journal:  Arq Bras Cir Dig       Date:  2018-07-02

2.  NEW BOWEL PREPARATION TECHNIQUE FOR COLONOSCOPY: CLINICAL TRIAL COMPARING AQUANET AND MANNITOL.

Authors:  Roberto Luiz Kaiser-Júnior; Luiz Gustavo DE-Quadros; Mário Flamini-Júnior; Mikaell Alexandre Gouvea Faria; Juan Carlos Ochoa Campo; Vera Lúcia DE-Oliveira; Idiberto José Zotarelli-Filho
Journal:  Arq Bras Cir Dig       Date:  2018-08-16

3.  Estimation of median effective effect-site concentration (EC50) during target-controlled infusion of propofol for dilatation and curettage - A prospective observational study.

Authors:  Velraj Jaya; P Madhula; Vr Hemanth Kumar; Daniel Rajadurai
Journal:  Indian J Anaesth       Date:  2022-03-24

4.  COLONOSCOPY: RANDOMIZED COMPARATIVE STUDY OF INSUFFLATION WITH CARBON DIOXIDE VERSUS AIR.

Authors:  Luiz Gustavo DE-Quadros; Roberto Luiz Kaiser-Júnior; Valter Nilton Felix; Lucio Villar; Josemberg Marins Campos; Vinicius Quintiliano Moutinho Nogueira; André Teixeira; Idiberto José Zotarelli-Filho
Journal:  Arq Bras Cir Dig       Date:  2017 Jul-Sep
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.